LP-284
- Generic Name
- LP-284
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 2412580-47-1
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Lantern Pharma Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT06132503
- Locations
- 🇺🇸
Cancer and Blood Specialty Clinic, Los Alamitos, California, United States
🇺🇸START Mountain Region, West Valley City, Utah, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath